Page last updated: 2024-09-03
imatinib mesylate and Venous Thromboembolism
imatinib mesylate has been researched along with Venous Thromboembolism in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Breccia, M; Chistolini, A; Di Prima, A; Fiori, L; Scalzulli, E; Serrao, A | 1 |
Other Studies
1 other study(ies) available for imatinib mesylate and Venous Thromboembolism
Article | Year |
---|---|
Concomitant Administration of Direct Oral Anticoagulants in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors.
Topics: Administration, Oral; Adult; Aged; Aniline Compounds; Anticoagulants; Cohort Studies; Female; Hemorrhage; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Nitriles; Protein Kinase Inhibitors; Pyrimidines; Quinolines; Retrospective Studies; Venous Thromboembolism | 2020 |